DK1504098T4 - Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion - Google Patents

Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion

Info

Publication number
DK1504098T4
DK1504098T4 DK03722867.3T DK03722867T DK1504098T4 DK 1504098 T4 DK1504098 T4 DK 1504098T4 DK 03722867 T DK03722867 T DK 03722867T DK 1504098 T4 DK1504098 T4 DK 1504098T4
Authority
DK
Denmark
Prior art keywords
stranded polynucleotide
reaction
population
parent
polynucleotide molecules
Prior art date
Application number
DK03722867.3T
Other languages
English (en)
Other versions
DK1504098T3 (da
Inventor
Christina Furebring
Roland Carlsson
Carl Arne Krister Borrebaeck
Hager Ann-Christin Malmborg
Original Assignee
Alligator Bioscience Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29551433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1504098(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0211369A external-priority patent/GB2388604B/en
Priority claimed from US10/321,195 external-priority patent/US7153655B2/en
Application filed by Alligator Bioscience Ab filed Critical Alligator Bioscience Ab
Publication of DK1504098T3 publication Critical patent/DK1504098T3/da
Application granted granted Critical
Publication of DK1504098T4 publication Critical patent/DK1504098T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK03722867.3T 2002-05-17 2003-05-16 Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion DK1504098T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0211369A GB2388604B (en) 2002-05-17 2002-05-17 A method for in vitro molecular evolution of protein function
US10/321,195 US7153655B2 (en) 1998-06-16 2002-12-17 Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
PCT/GB2003/002102 WO2003097834A2 (en) 2002-05-17 2003-05-16 A method for in vitro molecular evolution of protein function

Publications (2)

Publication Number Publication Date
DK1504098T3 DK1504098T3 (da) 2007-06-11
DK1504098T4 true DK1504098T4 (da) 2011-05-23

Family

ID=29551433

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03722867.3T DK1504098T4 (da) 2002-05-17 2003-05-16 Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
DK200401821A DK200401821A (da) 2002-05-17 2004-11-23 Fremgangsmåde til in vitro molekylær udvikling af proteinfunktion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200401821A DK200401821A (da) 2002-05-17 2004-11-23 Fremgangsmåde til in vitro molekylær udvikling af proteinfunktion

Country Status (10)

Country Link
US (1) US7262012B2 (da)
EP (1) EP1504098B2 (da)
JP (1) JP4372679B2 (da)
AT (1) ATE356871T1 (da)
AU (1) AU2003230027A1 (da)
CA (1) CA2485506C (da)
DE (1) DE60312507T3 (da)
DK (2) DK1504098T4 (da)
ES (1) ES2285118T5 (da)
WO (1) WO2003097834A2 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1095059T3 (da) * 1998-07-10 2006-10-02 Alligator Bioscience Ab Publ Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
EP1586583A3 (en) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Compounds that block C5a complement receptor and their use in therapy
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0708376D0 (en) 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905503D0 (en) * 2009-03-31 2009-05-13 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0920258D0 (en) 2009-11-19 2010-01-06 Alligator Bioscience Ab New medical agents and use thereof
GB201019086D0 (en) 2010-11-11 2010-12-29 Imp Innovations Ltd Bacterial methods
WO2012122135A2 (en) 2011-03-04 2012-09-13 Evolvemol, Inc. Apparatus and process for isolating specific physical items within a set of physical items
GB201115280D0 (en) 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
GB201311475D0 (en) 2013-06-27 2013-08-14 Alligator Bioscience Ab Polypeptides
CA2957146A1 (en) 2014-08-12 2016-02-18 Alligator Bioscience Ab Combination therapies with anti cd40 antibodies
CN108368510B (zh) 2015-09-30 2023-09-01 詹森生物科技公司 特异性结合人cd40的激动性抗体和使用方法
CN113892654A (zh) * 2021-10-21 2022-01-07 长春大学 一种以绿豆蛋白粉为原料制备免消化绿豆蛋白质的方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888286A (en) 1984-02-06 1989-12-19 Creative Biomolecules, Inc. Production of gene and protein analogs through synthetic gene design using double stranded synthetic oligonucleotides
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US6492107B1 (en) * 1986-11-20 2002-12-10 Stuart Kauffman Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
DE3590766T (da) 1985-03-30 1987-04-23
US4994368A (en) * 1987-07-23 1991-02-19 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5023171A (en) * 1989-08-10 1991-06-11 Mayo Foundation For Medical Education And Research Method for gene splicing by overlap extension using the polymerase chain reaction
US5573907A (en) * 1990-01-26 1996-11-12 Abbott Laboratories Detecting and amplifying target nucleic acids using exonucleolytic activity
WO1991015581A1 (en) * 1990-04-05 1991-10-17 Roberto Crea Walk-through mutagenesis
GB9015198D0 (en) * 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5858725A (en) * 1990-10-10 1999-01-12 Glaxo Wellcome Inc. Preparation of chimaeric antibodies using the recombinant PCR strategy
US5514568A (en) * 1991-04-26 1996-05-07 Eli Lilly And Company Enzymatic inverse polymerase chain reaction
US5512463A (en) * 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US5858657A (en) * 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
DE69230142T2 (de) * 1991-05-15 2000-03-09 Cambridge Antibody Technology Ltd. Verfahren zur herstellung von spezifischen bindungspaargliedern
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
US5521291A (en) * 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5733731A (en) 1991-10-16 1998-03-31 Affymax Technologies N.V. Peptide library and screening method
US5252479A (en) * 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
US5733753A (en) * 1992-12-22 1998-03-31 Novo Nordisk A/S Amplification of genomic DNA by site specific integration of a selectable marker construct
US5491074A (en) * 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
SE9304060D0 (sv) * 1993-12-06 1993-12-06 Bioinvent Int Ab Sätt att selektera specifika bakteriofager
US6117679A (en) * 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) * 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5834252A (en) * 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6309883B1 (en) * 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) * 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6395547B1 (en) * 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6361974B1 (en) * 1995-12-07 2002-03-26 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
US6352842B1 (en) * 1995-12-07 2002-03-05 Diversa Corporation Exonucease-mediated gene assembly in directed evolution
US6358709B1 (en) * 1995-12-07 2002-03-19 Diversa Corporation End selection in directed evolution
US6368798B1 (en) * 1995-12-07 2002-04-09 Diversa Corporation Screening for novel bioactivities
US5965408A (en) * 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US6171820B1 (en) * 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US6238884B1 (en) * 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US5830696A (en) * 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US5939250A (en) * 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US6096548A (en) * 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US5851804A (en) 1996-05-06 1998-12-22 Apollon, Inc. Chimeric kanamycin resistance gene
US5877001A (en) * 1996-06-17 1999-03-02 Diverso Corporation Amidase
US5763239A (en) * 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
US5925544A (en) * 1996-11-18 1999-07-20 Novo Nordisk A/S Method of homologous recombination followed by in vivo selection of DNA amplification
CN1208456C (zh) 1996-12-20 2005-06-29 诺维信公司 体内重组
US6326204B1 (en) * 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
DK1717322T3 (da) * 1997-01-17 2012-10-22 Codexis Mayflower Holdings Llc Udvikling af hele celler og organismer ved rekursiv sekvensrekombination
AU6029998A (en) * 1997-01-17 1998-08-07 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US6159687A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods for generating recombined polynucleotides
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
US6291165B1 (en) * 1997-03-18 2001-09-18 Novo Nordisk A/S Shuffling of heterologous DNA sequences
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
GB9712512D0 (en) * 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
WO1999021979A1 (en) * 1997-10-28 1999-05-06 Maxygen, Inc. Human papillomavirus vectors
US20010006950A1 (en) * 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
EP1090024A2 (en) * 1998-06-17 2001-04-11 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) * 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
US20020059659A1 (en) * 1998-08-12 2002-05-16 Maxygen, Inc. DNA shuffling to produce herbicide selective crops
JP2002522089A (ja) * 1998-08-12 2002-07-23 マキシジェン， インコーポレイテッド 除草剤選択性作物を生成するためのｄｎａシャッフリング
US20020151017A1 (en) * 1998-11-10 2002-10-17 Willem P. C. Stemmer Methods for obtaining a polynecleotide encoding a polypeptide having a rubisco activity
US6358712B1 (en) * 1999-01-05 2002-03-19 Trustee Of Boston University Ordered gene assembly
US6376246B1 (en) * 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) * 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) * 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
CA2364997A1 (en) * 1999-03-05 2000-09-08 Maxygen, Inc. Encryption of traits using split gene sequences
US6329178B1 (en) 2000-01-14 2001-12-11 University Of Washington DNA polymerase mutant having one or more mutations in the active site
JP3777158B2 (ja) * 2000-11-10 2006-05-24 アミコージェン・インコーポレイテッド 一方向性の一本鎖ｄｎａ切片を用いた組換えｄｎａライブラリーの製造方法
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
WO2002048351A2 (en) * 2000-12-12 2002-06-20 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function

Also Published As

Publication number Publication date
DE60312507T3 (de) 2011-08-18
AU2003230027A1 (en) 2003-12-02
EP1504098A2 (en) 2005-02-09
DK200401821A (da) 2004-11-23
US7262012B2 (en) 2007-08-28
DE60312507T2 (de) 2007-12-06
EP1504098B1 (en) 2007-03-14
CA2485506C (en) 2012-02-28
JP2005525820A (ja) 2005-09-02
ATE356871T1 (de) 2007-04-15
DK1504098T3 (da) 2007-06-11
CA2485506A1 (en) 2003-11-27
AU2003230027A8 (en) 2003-12-02
ES2285118T5 (es) 2012-09-21
WO2003097834A3 (en) 2004-02-19
EP1504098B2 (en) 2011-02-09
DE60312507D1 (de) 2007-04-26
US20060166198A1 (en) 2006-07-27
WO2003097834A2 (en) 2003-11-27
JP4372679B2 (ja) 2009-11-25
ES2285118T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
DK1504098T4 (da) Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
EP3470529A1 (en) Nucleic acid isothermal self-amplification method
ATE540110T1 (de) Oligonukleotid-leiterkonstruktion und system zur erzeugung von molekularer vielfalt
DE60025850D1 (de) Verfahren zur erzeugung von oligonukleotiden, im besonderen zur detektion amplifizierter restriktionsfragmente, die durch aflp erhalten wurden
ATE419388T1 (de) Nukleinsäureanreicherung
DK1948794T3 (da) Fremgangsmåde til molekylær evolution in vitro af proteinfunktion
ATE409235T1 (de) Verfahren zur herstellung von ascorbinsäurezwischenprodukten in wirtszellen
DE60110926D1 (de) Eine methode zur in vitro molekularen evolution der proteinfunktion
ATE469984T1 (de) Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
NO20016428D0 (no) Fremgangsmåter for kloning og fremstilling av fragmentkjeder med lesbart informasjonsinnhold
JP2004515248A5 (da)
DE60219632D1 (de) Verfahren zur herstellung von matrizen-dna und verfahren zur proteinherstellung in einem zellfreien proteinsynthesesystem unter verwendung davon
ATE310103T1 (de) Methode zur bestimmung von polynukleotidsequenzvariationen
EP3643788A1 (en) Pcr primer pair and application thereof
WO2003016550A3 (en) Compositions and methods comprising control nucleic acid
ATE417938T1 (de) Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DE69636725D1 (de) Verfahren zur trennung und/oder erkennung von dns-molekülen
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner
DE60217972D1 (de) Methode zur erhöhung der effizienz von enzymatischen aufreinigungsprozessen
WO2002103044A1 (en) Improved methods relating to amplification-based analysis of dna
DE60227669D1 (de) Verfahren zur herstellung von polynukleotidfragmenten zur verwendung im shuffling
ATE299929T1 (de) Biotechnologisches verfahren zur herstellung von n-acetylmannosamin
ES2190866A1 (es) Metodo para la insercion eficiente en sitios especificos de cualquier adn diana de intrones del grupo ii.